Treatment looks different for different people, depending on your diagnosis. We tailor your treatment plan to you.
Our myeloproliferative neoplasm (MPN) specialists work closely with you, your family and each other to get you back to health. At Fred Hutchinson Cancer Center, we provide all standard therapies for MPN and offer you access to the latest innovations through clinical trials.
ON THIS PAGE
Treatment Plan | Treatment Process | Monitoring Your Health | Supportive Care Services | Continuing Care
Treatment Plan
MPN treatment at Fred Hutch is highly customized for each patient’s needs.
How Do We Create Your Treatment Plan?
Your hematologist-oncologist works with an entire group of MPN specialists. They include other hematologist-oncologists and researchers who are looking for better ways to treat this disease.
Every week, this team gathers to discuss their patients’ treatment plans. This approach means each patient benefits from the experience of the whole group.
With support from the larger team, your physician will:
- Decide if your MPN needs treatment now, and if not, when treatment should happen
- Talk about the standard therapy for your type of MPN
- Find out if any clinical trials match your needs so you can think about joining them
Your hematologist-oncologist will walk you and your caregiver through the treatment plan that has been recommended for you. You will have a chance to share your personal preferences and options, and you will decide together what happens next.
Why Do Treatment Plans Differ?
The treatment plan we design for you depends on many things, including:
- Your MPN subtype
- Your age and overall health
- Your needs and preferences, like what type of treatment schedule works in your life and if you want to join a clinical trial
What Is The Standard Therapy For MPN?
There is no one way to treat everyone. Some people need infusions or other medications. Other people need chemotherapy. They might need a bone marrow transplant. Or they may not need any active treatment for years, but they should be carefully monitored over time. This is called watchful waiting.
At Fred Hutch, our standard always involves caring for you as a whole person. We help you get relief from side effects and provide many other forms of support, like integrative medicine, nutrition counseling and physical therapy.
Our patients can also choose to have promising new MPN therapies that you can only get through a clinical trial. Many people come to Fred Hutch for access to these studies. Your care team will tell you about studies that might be right for you, so you can think about joining them.
Cytoreductive Therapy
These medications reduce the number of blood cells. You might need cytoreductive therapy if you have a new blood clot, major bleeding, frequent phlebotomy treatments, enlarged spleen, high platelet count, high white blood cell count or symptoms that are getting worse.
Hydroxyurea (Hydrea®)
This chemotherapy drug is taken by mouth as a pill or capsule. It is used for high-risk category patients who cannot have frequent phlebotomy treatments and for patients with high blood counts and enlarged spleens.
JAK Inhibitors, Including Ruxolitinib, Fedratinib, Pacritinib
This drug is a JAK1/JAK2 inhibitor taken by mouth. It is a second-line therapy in adults who have had an inadequate response to, or who cannot take, hydroxyurea. JAK proteins send signals that affect the production of blood cells in the bone marrow. When JAKs send too many signals, your body makes too many blood cells. Ruxolitinib works by blocking the JAK proteins and cutting down on the signals.
Interferon Alfa-2b (Intron® A) and Interferon Alfa-2a (Roferon®-A) and Their Associated Sustained-Release Preparations, Peginterferon Alfa-2b (PEG-Intron®), Peginterferon Alfa-2a (Pegasys®) and Ropeginterferon Alfa-2b-njft (BESREMi®)
Interferon is a biological agent that boosts the immune system to fight the production of too many red blood cells. It may be used for patients who are either intolerant or resistant to hydroxyurea, or for patients that we do not recommend hydroxyurea for.
Anagrelide
This is in a group of medications that are used to slow down the production of platelets. It may be used to lower the risk of blood clots in patients who have thrombocythemia.
Monitoring Your Health
While you are in active treatment, your MPN care team will see you regularly for exams and tests to check:
- How well your treatment is working
- If there is any reason to change your treatment
- If you need help with side effects or supportive care services, like nutrition care or mental health counseling
We update your treatment plan based on the best scientific evidence as well as how your disease responds and what you and what you prefer.
Supportive Care Services
Along with treating your MPN, Fred Hutch provides a range of services to support you and your caregiver before, during and after treatment. This is part of how we take care of you — not just your disease.
From registered dietitians to chaplains, we have experts who specialize in caring for people with this condition. We understand this may be one of the most intense and challenging experiences you and your family ever go through. We are here to provide the care you need.
Learn about Supportive Care Services
When your disease is in remission and your active treatment ends, it is still important to get follow-up care on a regular basis. At follow-up visits, you will see the same Fred Hutch team who treated your MPN. They will check your overall health and look for signs that your MPN has come back (signs of recurrence).
Your team will also help with any long-term side effects (which go on after treatment ends) or late effects (which may start after treatment is over).